SPX 500, Daily
Updated

[02/10] SPX – GEX Until the First Weekly Expiration

437
The SPX opened with a huge gap-down in both the futures and CFD markets. After the previous two Fridays, there was a massive gap-down in the premarket each time. Everyone was expecting the same scenario again, but it seems the market quickly recovered from the put support at the 6000 level, and we are now steadily moving toward the positive GEX range.

Although we are still in the transition zone (where it’s easy to switch between positive and negative GEX territory), we may soon reach the HVL level at 6060, which, if I had to guess, might be adjusted during today’s premarket update.

The GEX levels align with the technical foundations:

🟢 6090–6100 to the upside is a bullish take-profit zone, and our purely positive GEX range is fairly narrow. If buying pressure is strong, above 6100 we could see a very strong positive gamma squeeze upward.

🔴 To the downside, “armageddon” could begin if the put support around 6010–6000, which held the sell-off this morning, fails to hold. The next target in a negative gamma squeeze could be 5950, followed by 5900.

The transition range is quite wide, and the market is expecting a volatile week (though I believe that from now on it’ll expect volatility every day for the next four years...).

The transition zone is sure to narrow by Friday. It’s worth paying attention to the premarket update around 6:45 AM, about three hours before the market opens!

If the red zone extends very deep afterward (for example, if it’s red below the HVL level all the way to the put support at around 5950), it indicates a significant downside risk compared to any potential rally—which I don’t think will change unless we get a breakout above 6100.

🔶 So, be cautious with those bullish horns—below 6100, we can’t talk about a confirmed breakout to the upside.
Trade active
GEX LEVEL UPDATE after monday close:

snapshot

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.